These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20563846)

  • 1. The practice of the first check cystoscopy following radiotherapy for the treatment of muscle-invasive (T3N0M0) bladder cancer: a UK national survey.
    Mohammed A; Hameed A; Shergill I; Barua J
    Int Urol Nephrol; 2011 Jun; 43(2):377-81. PubMed ID: 20563846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members.
    Matulay JT; Tabayoyong W; Duplisea JJ; Chang C; Daneshmand S; Gore JL; Holzbeierlein JM; Karsh LI; Kim SP; Konety BR; Li R; McKiernan JM; Messing EM; Steinberg GD; Williams SB; Kamat AM
    Urol Oncol; 2020 Oct; 38(10):796.e1-796.e6. PubMed ID: 32430255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of muscle invasion of bladder cancer by cystoscopy.
    Satoh E; Miyao N; Tachiki H; Fujisawa Y
    Eur Urol; 2002 Feb; 41(2):178-81. PubMed ID: 12074406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations.
    Kassouf W; Traboulsi SL; Schmitz-Dräger B; Palou J; Witjes JA; van Rhijn BW; Grossman HB; Kiemeney LA; Goebell PJ; Kamat AM
    Urol Oncol; 2016 Oct; 34(10):460-8. PubMed ID: 27368880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cystoscopy in non-muscle-invasive bladder cancer: when and how (rigid or flexible)].
    Cicione A; Cantiello F; Damiano R
    Urologia; 2013; 80 Suppl 21():11-5. PubMed ID: 23559127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Standards in the Endoscopic Management of Bladder Cancer: A Survey Evaluation among Urologists in German-Speaking Countries.
    Suarez-Ibarrola R; Hein S; Farin E; Waldbillig F; Kriegmair MC; Ritter M; Klingler HC; Herrmann TRW; Gratzke C; Miernik A
    Urol Int; 2020; 104(5-6):410-416. PubMed ID: 32209791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder-sparing radiotherapy for muscle-invasive bladder cancer: A survey of providers to determine barriers and enablers.
    Walker M; French SD; Doiron RC; Brennan K; Feldman-Stewart D; Siemens DR; Mackillop WJ; Booth CM
    Radiother Oncol; 2017 Nov; 125(2):351-356. PubMed ID: 28974310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of frequent cystoscopy on surgical care and cancer outcomes among patients with low-risk, non-muscle-invasive bladder cancer.
    Schroeck FR; Lynch KE; Li Z; MacKenzie TA; Han DS; Seigne JD; Robertson DJ; Sirovich B; Goodney PP
    Cancer; 2019 Sep; 125(18):3147-3154. PubMed ID: 31120559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey.
    Hendricksen K; Aziz A; Bes P; Chun FK; Dobruch J; Kluth LA; Gontero P; Necchi A; Noon AP; van Rhijn BWG; Rink M; Roghmann F; Rouprêt M; Seiler R; Shariat SF; Qvick B; Babjuk M; Xylinas E;
    Eur Urol Focus; 2019 Jul; 5(4):681-688. PubMed ID: 29074050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer.
    Lightfoot AJ; Rosevear HM; Nepple KG; O'Donnell MA
    Int J Urol; 2012 Nov; 19(11):988-93. PubMed ID: 22762480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder-Preserving Therapy Patterns of Care: A Survey of US Radiation Oncologists.
    Solanki AA; Martin B; Korpics M; Small C; Harkenrider MM; Mitin T
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):383-387. PubMed ID: 28871988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary bladder preservation for muscle-invasive bladder cancer: a survey among radiation oncologists of Lombardy, Italy.
    Jereczek-Fossa BA; Colombo R; Magnani T; Fodor C; Gerardi MA; Antognoni P; Barsacchi L; Bedini N; Bracelli S; Buffoli A; Cagna E; Catalano G; Gottardo S; Italia C; Ivaldi GB; Masciullo S; Merlotti A; Sarti E; Scorsetti M; Serafini F; Toninelli M; Vitali E; Valdagni R; Villa E; Zerini D; De Cobelli O; Orecchia R
    Tumori; 2015; 101(2):174-8. PubMed ID: 25744865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment.
    Moonen L; vd Voet H; de Nijs R; Hart AA; Horenblas S; Bartelink H
    Radiother Oncol; 1998 Nov; 49(2):149-55. PubMed ID: 10052880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic Variation in Cystoscopy Rates for Suspected Bladder Cancer between Female and Male Medicare Beneficiaries.
    Han DS; Zhou W; Seigne JD; Lynch KE; Schroeck FR
    Urology; 2018 Dec; 122():83-88. PubMed ID: 30138684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of histological stage based on cystoscopic appearances of newly diagnosed bladder tumours.
    During VA; Sole GM; Jha AK; Anderson JA; Bryan RT
    Ann R Coll Surg Engl; 2016 Nov; 98(8):547-551. PubMed ID: 27502337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
    Guney S; Guney N; Canogullari Z; Ergenekon E
    Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of low- versus high-intensity surveillance cystoscopy on surgical care and cancer outcomes in patients with high-risk non-muscle-invasive bladder cancer (NMIBC).
    Rezaee ME; Lynch KE; Li Z; MacKenzie TA; Seigne JD; Robertson DJ; Sirovich B; Goodney PP; Schroeck FR
    PLoS One; 2020; 15(3):e0230417. PubMed ID: 32203532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency Management of Priapism in the United Kingdom: A Survey of Current Practice.
    Bullock N; Steggall M; Brown G
    J Sex Med; 2018 Apr; 15(4):476-479. PubMed ID: 29454716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.